Hexagon Nutrition Reports Q1 FY27 Financials, Recommends Dividend

Consolidated Revenue: ₹104.31 crore
Consolidated Net Profit: ₹8.07 crore

Reader Takeaway: Strong revenue growth; watch foreign subsidiary viability and plant restructuring impact.

What just happened

Hexagon Nutrition Ltd announced its financial results for the first quarter of the fiscal year 2027 (Q1 FY27). The company reported consolidated revenue from operations of ₹104.31 crore and a consolidated net profit of ₹8.07 crore. Standalone revenue stood at ₹101.40 crore with a net profit of ₹9.83 crore.
The Board of Directors has recommended a final dividend of ₹0.30 paise per equity share for the financial year ended March 31, 2026. This recommendation is pending shareholder approval at the Annual General Meeting (AGM) scheduled for September 22, 2026. The record date for this dividend is September 15, 2026.

Why this matters

These results provide investors with a post-IPO financial update. The dividend announcement signals a commitment to shareholder returns. However, the company is also undergoing significant strategic restructuring, including the decommissioning of a manufacturing facility and managing challenges with its foreign subsidiaries.

The backstory

Hexagon Nutrition recently completed its Initial Public Offering (IPO) via a 100% Offer for Sale (OFS), listing on the NSE and BSE on June 12, 2026. The company also successfully merged its wholly-owned subsidiary, Hexagon Nutrition (Exports) Private Limited, with an appointed date of April 1, 2025. They have initiated the phased decommissioning of their Premix manufacturing facility in Nashik, Maharashtra.

What changes now

Investors will closely monitor the financial impact of the Nashik plant decommissioning and the effectiveness of management's turnaround efforts for its foreign subsidiaries in South Africa and Uzbekistan. The parent company has pledged financial support to these overseas units.

Risks to watch

A key watch point is the viability of foreign subsidiaries in South Africa and Uzbekistan, where auditors have highlighted a material uncertainty regarding their going concern status. Management's efforts to address these issues and provide financial support are critical.

Peer comparison

As a recently listed entity, direct, up-to-date peer comparison for this specific quarter is difficult without further context on competitors' results. However, the company operates in the nutrition and premix manufacturing sector.

Context metrics (time-bound)

• Q1 FY27 Consolidated Revenue: ₹104.31 crore
• Q1 FY27 Consolidated Net Profit: ₹8.07 crore
• Final Dividend Recommended: ₹0.30 per equity share
• AGM Date: September 22, 2026
• Dividend Record Date: September 15, 2026
• IPO Listing Date: June 12, 2026

What to track next

Investors should track the company's upcoming quarterly results, updates on the financial impact of the Nashik facility restructuring, and the progress of the turnaround strategies for its international subsidiaries.